Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 849
TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM8960(2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2...)
Affinity DataIC50: 8nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM10404(galantamine | (1S,12S,14R)-9-methoxy-4-methyl-11-o...)
Affinity DataIC50: 700nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294221(US9586925, Compound FAR-01-2 | US9586925, EXAMPLE ...)
Affinity DataIC50: 2.80E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294223(US9586925, Compound FAR-01-2OH | US9586925, EXAMPL...)
Affinity DataIC50: 4.20E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM8960(2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2...)
Affinity DataIC50: 7.10E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294220(US9586925, Compound FAR-02-2S | US9586925, Example...)
Affinity DataIC50: 7.90E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294226(US9586925, Compound FAR-01-1CA | US9586925, EXAMPL...)
Affinity DataIC50: 8.50E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294219(US9586925, Compound FAR-02-2RS | US9586925, Exampl...)
Affinity DataIC50: 1.09E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM11682(2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethyl...)
Affinity DataIC50: 1.10E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294225(US9586925, Compound FAR-01-2CA | US9586925, EXAMPL...)
Affinity DataIC50: 1.27E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294222(US9586925, Compound FAR-01-1 | US9586925, EXAMPLE ...)
Affinity DataIC50: 1.51E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294220(US9586925, Compound FAR-02-2S | US9586925, Example...)
Affinity DataIC50: 1.62E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294219(US9586925, Compound FAR-02-2RS | US9586925, Exampl...)
Affinity DataIC50: 1.79E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294223(US9586925, Compound FAR-01-2OH | US9586925, EXAMPL...)
Affinity DataIC50: 1.89E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294221(US9586925, Compound FAR-01-2 | US9586925, EXAMPLE ...)
Affinity DataIC50: 2.11E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM10404(galantamine | (1S,12S,14R)-9-methoxy-4-methyl-11-o...)
Affinity DataIC50: 2.19E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294222(US9586925, Compound FAR-01-1 | US9586925, EXAMPLE ...)
Affinity DataIC50: 2.47E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294224(US9586925, Compound FAR-01-1OH | US9586925, EXAMPL...)
Affinity DataIC50: 3.31E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM11682(2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethyl...)
Affinity DataIC50: 3.52E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294225(US9586925, Compound FAR-01-2CA | US9586925, EXAMPL...)
Affinity DataIC50: 4.00E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294226(US9586925, Compound FAR-01-1CA | US9586925, EXAMPL...)
Affinity DataIC50: 4.00E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent

TargetCholinesterase(Human)
Nobel IlaÇ

US Patent
LigandPNGBDBM294224(US9586925, Compound FAR-01-1OH | US9586925, EXAMPL...)
Affinity DataIC50: 4.00E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2019
Entry Details
Go to US Patent